Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002278 · ClinicalTrials.gov registry record · NA
A 28-Day Study of Diclazuril in the Treatment of Cryptosporidiosis in Patients With AIDS
A NA study of HIV Infections and Cryptosporidiosis, sponsored by Janssen.
- Completed
- Registry status
- NA
- Development phase
- 3
- Study locations
NCT00002278 is a NA study of HIV Infections and Cryptosporidiosis that has completed, run by Janssen. The trial reports 3 study locations across 1 state.
The verdict
NCT00002278, a NA study of HIV Infections and Cryptosporidiosis, has completed, sponsored by Janssen.
- COMPLETED
- Registry status
- NA
- Development phase
- 3
- Study locations
Study Summary
To evaluate the safety and efficacy of diclazuril capsules as a treatment for cryptosporidial related diarrhea in AIDS patients who have been treated in the double-blind study # JRD 64,433/1101 and have relapsed, or de-novo patients who have been diagnosed with cryptosporidial related diarrhea and who meet the inclusion and exclusion criteria of this protocol.
Conditions Studied
Interventions
- DRUG Diclazuril
Study Locations (3)
New York
- Bellevue Hosp / New York Univ Med Ctr - New York
- Cornell Univ Med Ctr - New York
- Saint Luke's - Roosevelt Hosp Ctr - New York
Trial Details
| Field | Value |
|---|---|
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00002278
The ClinicalTrials.gov registry entry for NCT00002278 describes a study currently listed as completed, categorized as NA. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Janssen, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with HIV Infections appearing as the primary indexed condition, and to 1 intervention - of which Diclazuril is the first listed.
NCT00002278 reports 3 study locations spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT00002278 about?
NCT00002278 is a clinical study titled "A 28-Day Study of Diclazuril in the Treatment of Cryptosporidiosis in Patients With AIDS". To evaluate the safety and efficacy of diclazuril capsules as a treatment for cryptosporidial related diarrhea in AIDS patients who have been treated in the double-blind study # JRD 64,433/1101 and have relapsed, or de-novo patients who have been diagnosed with cryptosporidial related diarrhea and w...
What is the current status of trial NCT00002278?
This trial is currently completed. It is a NA study.
What conditions does trial NCT00002278 study?
This clinical trial studies the following conditions: HIV Infections, Cryptosporidiosis.
What interventions are being tested in trial NCT00002278?
The interventions under investigation include: Diclazuril (DRUG).
Who is sponsoring clinical trial NCT00002278?
This trial is sponsored by Janssen, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00002278 being conducted?
This trial has 3 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
WiseApp for Spanish Speakers Living With HIV
RECRUITING · NA
-
Comprehensive HIV and Harm Prevention Via Telehealth
RECRUITING · NA
-
Substance Checking Outreach and Pre-Exposure Prophylaxis (PrEP) Engagement Study
RECRUITING · NA
-
Food as Medicine for HIV and Diabetes
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.